Zobrazeno 1 - 7
of 7
pro vyhledávání: '"M R, Dalesandro"'
Publikováno v:
Thrombosis research. 96(1)
Surface expression of P-selectin is known to be a marker of platelet activation in patients with acute coronary syndromes. However, direct comparisons of flow cytometer data may be obscured by differences in methodology, artifactual platelet activati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::fc63ee336189ae2917af6466b6c9bdf8
https://pubmed.ncbi.nlm.nih.gov/10554084
https://pubmed.ncbi.nlm.nih.gov/10554084
Publikováno v:
Thrombosis and haemostasis. 80(4)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::8c4a46c79162925ff93a74b342d3478e
https://pubmed.ncbi.nlm.nih.gov/9799011
https://pubmed.ncbi.nlm.nih.gov/9799011
Publikováno v:
Magnesium research. 11(2)
There has been some debate regarding the benefit of parenteral magnesium (Mg) in the treatment of acute myocardial infarction (AMI), due to conflicting results from animal studies and recent clinical trials. Several different hypotheses, proposing an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::80014ccd85a78686af3f2f02913a20a4
https://pubmed.ncbi.nlm.nih.gov/9675757
https://pubmed.ncbi.nlm.nih.gov/9675757
Autor:
V L, Serebruany, P A, Gurbel, A R, Shustov, M R, Dalesandro, C I, Gumbs, L B, Grabletz, R D, Bahr, E M, Ohman, E J, Topol
Publikováno v:
Stroke. 29(1)
Impaired platelet function has been reported in acute myocardial infarction (AMI) and stroke. However, prospective data on the changes of platelet status in patients before the occurrence of hemorrhagic stroke after thrombolytic therapy are unavailab
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::b2495a88326ca6fed37f139104748883
https://pubmed.ncbi.nlm.nih.gov/9731631
https://pubmed.ncbi.nlm.nih.gov/9731631
Autor:
G, Riethmüller, K, Deusch, M E, Sanders, M R, Dalesandro, S, Kiefersauer, C, Reiter, E P, Rieber
Publikováno v:
Immunology series. 59
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::5168641acd7627bd37ba14379ff26ad2
https://pubmed.ncbi.nlm.nih.gov/8461391
https://pubmed.ncbi.nlm.nih.gov/8461391
Autor:
J E, Looney, D M, Knight, M, Arevalo-Moore, H, Trinh, K Y, Pak, M R, Dalesandro, E P, Rieber, G, Riethmuller, P E, Daddona, J, Ghrayeb
Publikováno v:
Human antibodies and hybridomas. 3(4)
The use of murine anti-CD4 monoclonal antibodies (MAbs) has shown considerable promise for the treatment of allograft rejection and rheumatoid arthritis. We have constructed mouse-human anti-CD4 antibodies with the goal of increasing their clinical p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::e4fd11ab40b43caed2034c6f467d65dd
https://pubmed.ncbi.nlm.nih.gov/1477300
https://pubmed.ncbi.nlm.nih.gov/1477300
Autor:
M. R. Dalesandro, Eric K. Rowinsky, Hagop Youssoufian, A. L. Ervin-Haynes, J. Roecker, R. M. Schinagl
Publikováno v:
Journal of Clinical Oncology. 24:13000-13000
13000 Background: EGFR expression, as determined by IHC, is currently used to select patients for cetuximab therapy. Based on prior studies in colorectal cancer patients, approximately 60 to 75% of patients express EGFR. There is increasing evidence
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8dab04eadbe55c486a902a681bc9792a
https://doi.org/10.1200/jco.2006.24.18_suppl.13000
https://doi.org/10.1200/jco.2006.24.18_suppl.13000